Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,933
Closed -$352K 541
2023
Q4
$352K Sell
4,933
-843
-15% -$58.7K 0.02% 398
2023
Q3
$401K Sell
5,776
-596
-9% -$45K 0.03% 375
2023
Q2
$516K Sell
6,372
-86
-1% -$7.03K 0.03% 328
2023
Q1
$521K Buy
6,458
+614
+11% +$49.4K 0.04% 338
2022
Q4
$437K Sell
5,844
-99,167
-94% -$7.06M 0.04% 341
2022
Q3
$6.78M Buy
105,011
+4,375
+4% +$303K 0.63% 40
2022
Q2
$6.97M Buy
100,636
+1,449
+1% +$108K 0.61% 39
2022
Q1
$7.62M Buy
99,187
+78,532
+380% +$5.65M 0.56% 46
2021
Q4
$1.58M Buy
20,655
+162
+0.8% +$11.9K 0.1% 175
2021
Q3
$1.51M Buy
+20,493
New +$1.54M 0.11% 156
2020
Q3
Sell
-31,225
Closed -$1.78M 258
2020
Q2
$1.78M Sell
31,225
-139
-0.4% -$6.82K 0.21% 71
2020
Q1
$1.1M Buy
+31,364
New +$1.49M 0.16% 83

Other funds holding HOLX

Summit Global Investments's HOLX Position: Q1 2024 in Review

Summit Global Investments sold out of Hologic (HOLX) in Q1 2024, closing a stake of 4,933 shares — an estimated $352K sold.

Summit Global Investments first reported a position in HOLX in Q1 2020 and held it in 12 quarters. The position peaked at $7.62M in Q1 2022. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Summit Global Investments reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Summit Global Investments sold 4,933 Hologic shares in Q1 2024, an estimated $352K.
  • Summit Global Investments first reported a position in Hologic in Q1 2020 and held it in 12 quarters.
  • Summit Global Investments's Hologic position peaked at $7.62M in Q1 2022.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Summit Global Investments's 13F filing for Q1 2024, filed 29 Apr 2024.